AI Will Fix Drug Discovery, Unless Regulation Fails to Catch Up
AI is beginning to outperform traditional pipelines in identifying drug candidates.
Not hypothetically: measurably.
Modern generative platforms can now design molecules that bind their targets with high affinity, minimize off-target effects, and